Bone density and treatment response in a large cohort of patients with type 1 Gaucher disease

被引:0
|
作者
Anstett, Kara [1 ]
Lau, Heather A. [1 ]
机构
[1] NYU, Langone Hlth, New York, NY USA
关键词
D O I
10.1016/j.ymgme.2018.12.034
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
18
引用
收藏
页码:S23 / S23
页数:1
相关论文
共 50 条
  • [11] Follow-up of bone disease in a large cohort of Gaucher disease
    Andrade Campos, Marcio M.
    Roca Espiau, Mercedes
    Valero Tena, Esther
    Giraldo, Pilar
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S20 - S20
  • [12] Skeletal involvement in type 1 Gaucher disease: Not just bone mineral density
    Baldini, M.
    Casirati, G.
    Ulivieri, F. M.
    Cassinerio, E.
    Chalouhi, K. Khouri
    Poggiali, E.
    Borin, L.
    Burghignoli, V.
    Cesana, B. M.
    Cappellini, M. D.
    BLOOD CELLS MOLECULES AND DISEASES, 2018, 68 : 148 - 152
  • [13] The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease - Response
    Charrow, J.
    Dulisse, B.
    Grabowski, G. A.
    Weinreb, N. J.
    CLINICAL GENETICS, 2007, 72 (02) : 161 - 161
  • [14] Proinflammatory bone cytokine profile in patients with Type 1 Gaucher disease
    Gervas, J.
    Quintana, L.
    Giraldo, P.
    Pocovi, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 : S67 - S67
  • [15] Interest of bone scintigraphy in patients with type 1 Gaucher's disease
    Ghazzar, N
    Lebtahi, R
    Belmatoug, N
    Delahaye, N
    Genin, R
    Faraggi, M
    Le Guludec, D
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1044 - 1044
  • [16] BONE MINERAL DENSITY RESPONSE TO ENZYME REPLACEMENT THERAPY OVER 2 YEARS IN ADULTS WITH TYPE 1 GAUCHER DISEASE
    Zimran, A.
    Gonzalez, D. E.
    Kabra, M.
    Lukina, E. A.
    Giraldo, P.
    Kisinovsky, I
    Bavdekar, A.
    Ben Dridi, M-F
    Gupta, N.
    Kishnani, P. S.
    Mehta, A.
    Elstein, D.
    Wang, N.
    Hangartner, T. N.
    Crombez, E.
    Ben Turkia, H.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S149 - S149
  • [17] Gaucher disease: bone and joint complications in a cohort of UK patients
    Blincoe, M.
    Bruce, R.
    Goodwin, S.
    Hughes, D.
    Milligan, A.
    Richfield, L.
    Mehta, A. B.
    ACTA PAEDIATRICA, 2007, 96 : 106 - 107
  • [18] Evaluation of glucosylsphingosine as a biomarker of the eliglustat treatment response in patients with Gaucher disease type 1 (GD1)
    Peterschmitt, M. Judith
    Zhang, Kate
    Liu, Lin
    Cox, Gerald F.
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S94 - S95
  • [19] A Comprehensive Study of Bone Manifestations in Adult Patients with Gaucher Disease type 1
    Oliveri, Beatriz
    Gonzalez, Diana
    Quiroga, Felisa
    Silva, Claudio
    Rozenfeld, Paula
    Lis, Camilo
    Riemersma, Omar
    Kot, Martin
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 299 - 299
  • [20] Platelet Activation and Reactivity in a Large Cohort of Patients with Gaucher Disease
    Revel-Vilk, Shoshana
    Naamad, Mira
    Frydman, Dafna
    Freund, Michael R.
    Dinur, Tama
    Istaiti, Majdolen
    Becker-Cohen, Michal
    Falk, Roni
    Broide, Eti
    Michelson, Alan D.
    Frelinger, Andrew L., III
    Zimran, Ari
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (06) : 951 - 960